Stefan K.f. Schwabe, Executive Vice President R&D at SUPERNUS PHARMACEUTICALS INC (SUPN), sold 3,631 shares at $16.44 ($60K) on 2015-06-11, disclosed to the SEC on 2015-06-12.
Scheduled sale ($60k) by Executive Vice President R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.32 | 1,345 | $22K | 36.9% |
| 2 | $16.44 | 2,286 | $38K | 63.1% |
| Total | $16.40 avg | 3,631 | $60K | 100% |
| Filing → |
| SUPN | SELL | 2018-06-19 | $3.3M | — | Filing → |
| SUPN | SELL | 2017-09-11 | $4.4M | — | Filing → |
| SUPN | SELL | 2015-07-29 | $50K | — | Filing → |